# Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children

> **NCT00076999** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 115 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** TPV oral solution
- **DRUG:** TPV oral solution
- **DRUG:** RTV oral solution
- **DRUG:** RTV oral solution

## Key facts

- **NCT ID:** NCT00076999
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2010-06
- **Final completion:** —
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2014-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00076999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00076999, "Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00076999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*